Sept 4 (Reuters) - Mayne Pharma Group Ltd (MYX) :
- MAYNE PHARMA EXECUTES ASSET PURCHASE AGREEMENT WITH NOVAN AND EPI HEALTH FOR RHOFADE®
- TERMS OF DEAL ARE US$8 MILLION IN CASH AT CLOSING PLUS ASSOCIATED CURE COSTS NOT TO EXCEED US$1.5 MILLION
News: MYX Mayne Pharma Executes Asset Purchase Agreement With Novan And EPI Health
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.16 |
Change
-0.050(0.96%) |
Mkt cap ! $419.2M | |||
| Open | High | Low | Value | Volume |
| $5.22 | $5.25 | $5.07 | $470.4K | 90.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 738 | $5.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.16 | 282 | 4 |
View Market Depth
| Last trade - 12.44pm 23/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |